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Global 30 UTR shortening has a limited effect
on protein abundance in proliferating T cells
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Alternative polyadenylation is a cellular mechanism that generates mRNA isoforms differing
in their 30 untranslated regions (30 UTRs). Changes in polyadenylation site usage have been
described upon induction of proliferation in resting cells, but the underlying mechanism and
functional signiﬁcance of this phenomenon remain largely unknown. To understand the
functional consequences of shortened 30 UTR isoforms in a physiological setting, we used 30
end sequencing and quantitative mass spectrometry to determine polyadenylation site usage,
mRNA and protein levels in murine and human naive and activated T cells. Although 30 UTR
shortening in proliferating cells is conserved between human and mouse, orthologous genes
do not exhibit similar expression of alternative 30 UTR isoforms. We generally ﬁnd that 30 UTR
shortening is not accompanied by a corresponding change in mRNA and protein levels. This
suggests that although 30 UTR shortening may lead to changes in the RNA-binding protein
interactome, it has limited effects on protein output.
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E
xpression of messenger RNA (mRNA) precursors tran-
scribed by RNA polymerase II requires recognition and
processing of signals in the pre-mRNA by the cleavage and
polyadenylation factors to guide proper formation of 30 ends.
Most mammalian genes have multiple polyadenylation (poly(A))
sites1,2, whose regulated selection leads to the production of
alternative mRNA forms that differ in localization, stability and/
or protein-coding potential. A systematic shift towards coding
region-proximal 30 end processing sites, leading to an overall
shortening of 30 untranslated regions (30 UTRs) was recently
observed in activated compared with naive lymphocytes3 as well
as in cells that proliferate rapidly4,5. The differentiation of
embryonic stem cells and, conversely, the induction of
pluripotency in somatic cells, are associated with changes in
opposite directions in 30 UTR lengths2,6,7. The functional
signiﬁcance of this regulation is not well understood. Initial
studies suggested that the lack of microRNA (miRNA)-binding
sites in the shortened 30UTRs leads to an increased stability of the
mRNAs and an increased protein output3,4. This conjecture was
later refuted by a transcriptome-wide analysis that was carried out
in mouse embryonic ﬁbroblasts, where small differences in the
relative stability of 30 UTR isoforms were found8. MiRNAs are
only one class of regulators that act on 30 UTRs, guiding the
RNA-induced silencing complexes to target mRNAs to increase
their decay rate and reduce translation9,10. The 30 UTRs contain
binding sites for many RNA-binding proteins (RBPs) and
integrate a variety of signals for mRNA localization, decay and
translation. Of the hundreds of RBPs that bind and potentially
regulate various aspects of mRNA metabolism11,12, at least some,
such as the human antigen R (HuR)13 and the A/U-rich-element-
binding factor-1 (also known as the heterogeneous nuclear
ribonucleoprotein D or hnRNPD)14, have been reported to
increase mRNA stability. A very recent study that was carried out
in yeast15 found that the stability of transcripts is not correlated
with the length of their 30 UTRs. However, the protein that
appeared to cause the largest difference in decay rates between 30
UTR isoforms in this study, Puf3, had an overall destabilizing
effect (presumably on the longer 30UTR isoforms, containing
additional Puf3-binding sites compared with the shorter 30 UTR
isoforms). Thus, the functional relevance of the observed
systematic reduction in 30 UTR lengths in relation to cell
proliferation remains unclear. To determine the consequences
and functional relevance of 30 UTR shortening during
lymphocyte activation, we undertook a systematic investigation
of the changes in the poly(A) site usage and in the protein output
of the corresponding genes in mouse and human T cells.
Results
Activated T cells express mRNAs with shortened 30 UTRs. We
focused our investigation on the T cell activation system, in which
the 30 UTR shortening was initially described3. We dissected
spleen and lymph nodes from C57BL/6 mice and isolated T cells
by MACS puriﬁcation. T cells were activated for 72 h with CD3/
CD28 Dynabeads and IL-2 (see Methods) and libraries of 30 ends
of mature mRNAs were prepared and processed with the A-seq
protocol as described previously16. Excluding reads that may
result from internal priming, we identiﬁed 269,751 high-
conﬁdence poly(A) sites in the mouse genome, to which a total
of 32,388,835 reads mapped (Supplementary Table 1). For each
library, more than 70% of the reads mapped to terminal exons of
transcripts and only a small fraction (less than 0.5%) to other
exons (Fig. 1a). Compared with resting T cells, the density of 30
end sequencing reads in terminal exons showed a clear and highly
reproducible shift towards the 50 end of terminal exons in the
activated T cells (Fig. 1b).
To further validate the quality and reproducibility of our
results, we compared libraries on gene-by-gene basis using the
number of reads mapped to terminal exons of transcripts
assigned to a particular gene as a proxy for the expression level
of a gene. Requiring a minimal expression level of ﬁve reads per
million in at least one of the four libraries, we identiﬁed 9,928
genes as being expressed in naive and activated murine T cells.
Biological replicates of both naive and activated T cells showed
very high correlation (rZ0.94; Supplementary Fig. 1). The genes
that were upregulated in activated T cells showed a clear
enrichment of cell cycle-associated Gene Ontology (GO) terms,
whereas immune system-related GO terms were most enriched
among downregulated genes (Supplementary Table 2). These
results are consistent with the physiological state of the cells and
further demonstrate that our 30 end sequencing data accurately
reﬂect transcript-level changes.
To investigate the dynamics of 30 end processing, we ﬁrst
clustered the poly(A) sites that were very closely spaced and
probably the result of imprecise 30 end cleavage and identiﬁed
distinct poly(A) sites16. The nucleotide distribution in regions
ﬂanking the inferred sites and the presence of upstream
polyadenylation signals indicate that our strategy allowed us to
identify genuine poly(A) sites (Supplementary Fig. 2A,B). We
then restricted our analysis to tandem poly(A) sites that were
located in the same terminal exon, as was done in a previous
study3. Overall, we inferred that 3,116 genes undergo alternative
polyadenylation (APA) at tandem poly(A) sites (Supplementary
Table 3). The number of reads assigned to poly(A) sites in the 50
half and the 30 half of terminal exons showed good reproducibility
between biological replicates indicating that our data can be used
to analyse the relative use of alternative poly(A) sites in different
conditions (Supplementary Fig. 2C).
As expected from a previous study3, there was a marked shift
towards increased usage of proximal poly(A) sites in activated
compared with naive T cells (Fig. 1c). The shift is not restricted to
a small subset of genes, but affected the entire transcriptome
(Fig. 1d). That is, more than 70% of genes showed an increased
use of proximal poly(A) sites upon T cell activation.
We used the DEXSeq software to analyse the differential use of
poly(A) sites17. A total of 157 genes showed a signiﬁcant
difference (P-value r0.05) in the proximal-to-distal poly(A) site
use between naive and activated T cells (Supplementary Table 4),
and 150 of these genes (96%) had an increased abundance of
proximal transcript isoforms in activated T cells. This set includes
Bcl2, Creb1 and Tnfrsf9 (CD137), genes that are known to
inﬂuence proliferation18–20. Whereas the increased proximal
poly(A) site use of Bcl2 and Tnfrsf9 is associated with increased
expression, consistent with the initial reports of the effect of 30
UTR shortening on gene expression, the expression of Creb1, is
rather reduced, at least at the mRNA level. An example of a gene
with a marked shift towards increased proximal poly(A) site use
upon T cell activation is shown in Supplementary Fig. 3A, which
depicts a CLIPZ21 genome browser screenshot of the 30 UTR of
Reep5. It is well known that upon activation, T cells undergo a
dramatic remodelling of the cytoskeleton22. Some of the genes
that are involved in this process also show a signiﬁcantly higher
use of proximal poly(A) sites. These are Pak1 and Prkca (PKCa),
which are involved in signalling transduction cascades, as well as
Wasf2 (WAVE2)23, Marcks24 or Jmy25, which interact directly
with actin. Again in contrast to the expectation that the stability
of short 30 UTR isoforms is higher compared with the long 30
UTR isoforms4, all of these immune response-related genes are
downregulated at the mRNA level, in spite of their increased use
of proximal poly(A) sites. Moreover, when we analysed separately
genes that are signiﬁcantly downregulated or upregulated at the
mRNA level upon T cell activation, we found that downregulated
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genes showed a more pronounced 30 UTR shortening than
upregulated genes (Supplementary Fig. 3B). This motivated us to
investigate the relation between the change in poly(A) site use
and the change in mRNA/protein abundance in more detail.
Regulatory element content of 30 UTR isoforms. Among the
regulatory elements that are lost when proximal poly(A) sites are
used more frequently, are binding sites for miRNAs that in naive
T cells could contribute to the repression of gene expression3. To
assess the consequence of 30 UTR shortening on the miRNA-
mRNA interactome of T cells, we retrieved miRNA target
predictions from the ElMMo database26 and counted the number
of target sites for each miRNA seed family in the common and
alternative parts of the 30 UTRs of genes with tandem poly(A)
sites (Supplementary Table 5). MiRNA target sites that are
located between the most proximal and most distal poly(A) site in
the alternative 30 UTR region constitute a signiﬁcant fraction of
all predicted target sites. This is a reﬂection of the large change in
30 UTR length that is associated with T cell activation. For
example, 65% of all the target sites predicted for the miR-29a seed
family are located in the alternatively processed region of the 30
UTRs. To examine which miRNA regulators would be most
affected by 30 UTR shortening, we carried out the following test.
Each site predicted by ElMMo has an associated probability of
being under evolutionary selection. By summing the probabilities
of individual binding sites in a 30 UTR, we obtained an expected
number of sites that are under selection. Performing this
computation for individual transcript isoforms with their
corresponding expression levels estimated based on 30 end
sequencing, we obtained expected numbers of sites in the
isoforms produced in a speciﬁc condition (activated and naive
T cells). As expected from a global shortening of 30 UTRs, we ﬁnd
a net loss of target sites for all miRNAs. However, the loss of
target sites by 30 UTR shortening does not affect all miRNAs to a
similar degree. To identify which miRNAs would be most affected
by the 30 UTR shortening, we randomized the predicted
interactions involving the alternative parts of 30 UTRs. This
amounts to randomizing the ‘labels’ that indicate which miRNA
binds an individual site. Computing the z-score of the observed
change in the number of sites relative to what would be expected
from the randomized data set, we found large differences between
miRNAs. In particular, miRNAs that have been implicated in the
regulation of cell proliferation appear at the extreme of the
z-score range, some (miR-17, miR-365 and miR-135a27–29)
losing more sites than expected and others (miR-26a, miR-103
(refs 30,31) losing less sites than expected (Fig. 2a). MiRNAs with
a cell type-speciﬁc expression show a less extreme pattern of site
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Figure 1 | 30 end sequencing reveals increased proximal poly(A) site usage upon activation of murine T cells. (a) Annotation of reads obtained from
mRNA 30 end sequencing of naive and activated T cells. Two biological replicates were used for each condition. (b) Coverage of terminal exons by
30 end sequencing reads as a function of the distance from the exon start. Activated Tcells show increased coverage of the 50 compared with the 30 region
of terminal exons, resulting from preferential use of proximal poly(A) sites. (c) Contour plot of the relative use of proximal and distal poly(A) sites in naive
and activated T cells. Only genes with tandem poly(A) sites are shown. Genes that were identiﬁed to undergo signiﬁcant changes in poly(A) site
use are marked by coloured triangles with blue indicating increased use of the proximal poly(A) site and red indicating increased use of the distal
poly(A) site in activated Tcells. (d) Cumulative distribution function of the change in proximal vs distal poly(A) sites between pairs of samples (data shown
in c). The shift towards increased usage of proximal poly(A) sites is statistically highly signiﬁcant (P-values obtained by Mann–Whitney test on
3,116 genes with tandem poly(A) sites).
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loss. These results indicate that APA at proximal poly(A)
sites in proliferating cells does impact the susceptibility of the
corresponding genes to regulation by miRNAs that themselves
are involved in cell proliferation.
We similarly evaluated the change in the susceptibility of
transcripts to regulation by RBPs. Binding motifs for a relatively
large set of RBPs were recently published in the form of positional
weight matrices (PWMs)32. Based on these PWMs and on the
alignments of a number of genomes (see Methods), we predicted
evolutionarily conserved RBP-binding sites in the 30 UTRs of
expressed genes with a method that was introduced previously33.
Applying the procedure that we described above for miRNAs
starting from the inferred probabilities of RBP-binding sites to be
under evolutionary selection, we determined which RBPs lose the
most or least sites upon increased use of proximal poly(A) sites,
compared with what we would expect by chance (Fig. 2b). As for
miRNAs our analysis revealed large differences between
individual RBPs. The expected impact of this regulation is,
however, more complex because in contrast to miRNAs, for
which the evidence for target destabilization is overwhelming10,
RBPs have a variety of functions. An individual RBP frequently
acts at multiple levels of gene regulation, including APA34.
Nonetheless, Ray et al.32 have already associated a few of the
RBPs from their study with changes in mRNA stability. These
proteins are indicated by the red (destabilizers) and blue
(stabilizers) colours in Fig. 2b. We do not observe a clear trend
of destabilizing RBPs losing more sites and stabilizing RBPs
losing less sites than expected by chance, which would be
consistent with the small bias of shorter 30 UTR isoforms being
more stable than the corresponding long 30 UTR isoforms8. Two
proteins with the best established function in mRNA stabilization,
ELAVL1 (HuR) and PUM2 (Pumillio 2), appear to be losing less
sites than expected. To facilitate further investigations into the
impact of 30 UTR shortening on the fate of individual mRNAs, we
have summarized the transcripts that are predicted to be
regulated by those regulators whose impact on the
transcriptome is most affected by the systematic change in
poly(A) site use (Supplementary Data 1).
The impact of 30 UTR shortening on mRNA abundance. The
above analysis suggests that, consistent with the conclusions
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Figure 2 | Quantiﬁcation of the loss of regulatory elements upon 30 UTR shortening. Inﬂuence of 30 UTR shortening on miRNA (a) and RBP (b) target
sites. The x axis represents the z-score of the loss of binding sites obtained by comparing the observed loss of target sites with what would be
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drawn from the initial studies of 30 UTR shortening3,4,
preferential processing at proximal poly(A) sites in proliferating
cells leads to an overall loss of destabilizing sequence elements.
This would be expected to lead to increased expression of genes
with tandem poly(A) sites, yet it is not what we observed in our
initial analysis of genome-wide gene expression changes. We next
focused on genes with a simple pattern of polyadenylation,
considering only genes with tandem poly(A) sites and genes with
a single poly(A) site, and excluding genes with more complex
patterns of APA (such as alternative terminal exons). We further
restricted our set to genes for which spurious A-seq reads in the
rest of the gene body including cryptic intronic sites accounted
for at most 10% of the reads that were assigned to main poly(A)
sites. We estimated the overall mRNA expression level of each
gene as the sum of A-seq reads assigned to poly(A) sites located
in the terminal exon. Comparing the change in total mRNA levels
between naive and activated T cells for genes with two, three or
four tandem poly(A) sites relative to genes with a single poly(A)
site, we found a slight trend of upregulation of genes with
multiple poly(A) sites in activated cells (Fig. 3a). Considering
genes with precisely two poly(A) sites, we asked whether the
change in total mRNA level can be attributed to the change in the
relative use of proximal and distal poly(A) sites. If gene
expression was mainly regulated through APA with the short 30
UTR isoform being signiﬁcantly more stable than the long
isoform, we would expect a positive correlation between the
change in the total mRNA level and the change in proximal vs
distal polyadenylation site use. As shown in Fig. 3b, we did not
detect such a relationship.
The observed abundance of short and long 30 UTR isoforms in
different conditions depends not only on the relative rates of
polyadenylation at the two sites, but also on the overall rates of
transcription and the relative rates of decay of the two transcript
forms in the two conditions. To estimate the relative decay rates
of short and long isoforms from the 30 end sequencing data,
eliminating the effect of confounding factors, we developed a
mathematical model (described in Methods) based on the
assumption that the distribution of changes in the transcription
rate of genes between activated and naive T cells is similar for
genes with a single poly(A) site and genes with two tandem
poly(A) sites.
The contour plot of the log likelihood of the data for the 712
genes with two tandem poly(A) sites under the model, as a
function of the mean and standard deviation of the log-ratio of
the decay rates of long and short isoforms is shown in Fig. 3c. We
infer that mz, the average of the log-ratio of decay rates is located
between  0.84 and 0.95. Thus, consistent with a recent study in
which the decay rates of long and short isoforms were estimated
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Figure 3 | Evaluation of changes in mRNA levels in naive and activated murine Tcells with respect to changes in poly(A) site usage. (a) Comparison of
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in mouse ﬁbroblasts8, we found little evidence for short 30 UTR
isoforms being generally more stable compared with long 30 UTR
isoforms. Because 30 UTR-mediated interactions with RBPs may
also affect the translation rates of mRNAs, we next evaluated the
protein output of genes with tandem poly(A) sites in naive and
activated T cells.
The impact of 30 UTR shortening on protein abundance. To
quantify dynamic protein changes on a system-wide level,
we combined high mass accuracy mass spectrometry with iso-
baric tandem mass tagging (TMT)35 and extensive off-gel
electrophoresis sample fractionation (Fig. 4a)36. Performing our
experiment in biological duplicates we obtained a total of 138,816
peptide-spectral matches, 48,113 unique peptides and overall
quantiﬁed 6,187 protein clusters/genes at 1% false discovery
rate. It has been reported that ratio compression arising from
co-isolated peptides is prevalent with TMT-labelled peptides
and needs to be controlled to achieve accurate protein
quantiﬁcation37. Therefore, we carried out additional unbiased,
label-free quantiﬁcations (LFQs) of all samples. As reported
previously38,39, we observed a good linear correlation of TMT
and LFQ protein ratios (Supplementary Fig. 5A,B). This
suggested that the ratio compression of TMT can be largely
corrected by an average compression factor38 and we therefore
recalculated all TMT ratios accordingly (see Supplementary
Methods).
Analysis of protein expression data revealed the expected high
correlation between replicate measurements (Supplementary
Fig. 4A), and quantitative western blots conﬁrmed the protein-
level changes between naive and activated mouse T cells for ten
randomly selected proteins (see Supplementary Table 6). Further-
more, direct comparison of mRNA levels to protein levels (iBAQ
derived from LFQ) shows correlations comparable to those
recently reported for a variety of tissues (Supplementary
Fig. 5C)40. The changes in total mRNA levels determined as
described in the previous section also correlated well with the
changes in the corresponding protein levels between activated and
naive T cells (Fig. 4b).
We then asked whether genes with tandem poly(A) sites show
a systematic change in protein levels compared with genes with a
single poly(A) site (Fig. 4c) and found that for none of the groups
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Figure 4 | Inﬂuence of 30 UTR shortening on protein levels in murine T cells. (a) Quantitative mass spectrometry (liquid chromatography-mass
spectrometry (LC-MS))-based proteomics workﬂow. Proteins extracted from naive and activated mouse and human T cells were digested and subjected to
label-free and tandemmass tag (TMT) quantiﬁcation, respectively. The TMT-labelled peptides were further fractionated using isoelectric focusing before LC-MS
analysis to increase proteome coverage. Finally, the ratios obtained by the TMTapproach were correlated with the label-free quantities to correct for possible
ratio distortion effects in the ﬁnal TMT-based quantitative data sets, which comprised more proteins than the data sets based on LFQ. (b) Correlation of mRNA
and protein abundance changes between activated and naive Tcells. (c) Change in protein abundance between activated and naive Tcells for genes with one to
four or more tandem poly(A) sites. (d) Correlation between the change in proximal poly(A) site use and the change in protein level.
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with multiple tandem poly(A) sites could a signiﬁcant difference
be detected. Moreover, similar to the results obtained from the
corresponding analysis on the mRNA level, we found no
correlation between the change in proximal vs distal poly(A) site
use and the change in protein levels (Fig. 4d). These data indicate
that 30 UTR shortening does not have the same consequence on
the mRNA/protein abundance of all affected genes.
Weak evolutionary conservation of APA. To determine whether
the regulation of polyadenylation at tandem poly(A) sites is
evolutionarily conserved, we performed 30 end sequencing and
quantitative proteomics on naive and activated T cells obtained
from a human blood donor. We found that similar to the
mouse T cells, human T cells also had a pronounced increase in
the use of proximal polyadenylation sites upon activation
(Supplementary Fig. 6A,B). Also similar to the mouse T cells, the
change in polyadenylation site use does not correlate with the
change in gene expression, neither at the mRNA (Fig. 5a) nor at
the protein level (Fig. 5b). We then investigated to what extent the
changes in gene expression in the T cell activation system are
conserved between mouse and human. We used the NCBI
HomoloGene database41 to infer mouse–human orthologous
genes. Comparing the changes in expression of orthologous
genes, we found a good correlation at both the mRNA (Fig. 5c)
and the protein (Supplementary Fig. 6C) level. However, the
change in the relative use of tandem poly(A) sites is not
conserved. Of the 1,734 genes that show regulation by a tandem
poly(A) site mechanism in both murine and human T cells, 691
genes share the same number of tandem poly(A) sites in both
species. Analysis of this set of genes (Fig. 5d) and the bigger set of
genes that generally undergo APA in both species
(Supplementary Fig. 6D) did not reveal a correlation between
the changes in the relative use of alternative poly(A) sites of
orthologous genes. The set of genes that showed a strong (at least
4-fold, n¼ 64) shift to proximal poly(A) site use in both human
and murine T cells is not signiﬁcantly enriched in any particular
GO category. However, genes that are most enriched in this set
are related to ‘stem cell division’ (adj. P¼ 0.26) and ‘positive
regulation of mitotic cell cycle’ (adj. P¼ 0.28). Last, we
investigated whether the same RBP and miRNA regulators
would be affected by 30 UTR shortening in human and mouse.
We therefore predicted target sites of RBPs and miRNAs in the
alternatively processed human 30 UTRs and compared the z-
scores of individual regulators between human and mouse
(Supplementary Fig. 6E,F). Indeed, we observed some degree of
conservation at this level. For example, we inferred that miRNAs
of the Mir17 cluster lose more sites than expected in both systems
(mouse: z-score¼  2.1, human: z-score¼  1.0), whereas
the RBP PUM2, which has a stabilizing effect on its targets,
retains more sites than expected (mouse: z-score¼ 2.1, human:
z-score¼ 1.3).
Our analysis thus indicates that, although the process of 30
UTR shortening in dividing cells is conserved between mouse and
human, it is not highly conserved at a quantitative level and on a
gene by gene basis. Furthermore, our results indicate that APA at
tandem poly(A) sites contributes little to the mRNA and protein
output of individual genes. Rather, what appears to be conserved
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Figure 5 | Evolutionary conservation of alternative polyadenylation at tandem poly(A) sites. Assessment of the impact of 30 UTR shortening on
mRNA (a) and protein (b) levels in naive and activated human T cells. (c) Comparison of changes in mRNA levels upon T cell activation in murine and
human T cells. (d) Comparison of changes in poly(A) site use upon T cell activation in murine and human T cells. Only orthologous genes that
showed the same number of alternative poly(A) sites in mouse and human were considered.
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is the restructuring of the RBP and miRNA interactome. That is,
even though the 30 UTR shortening of orthologous genes is poorly
conserved, the RBPs and miRNAs whose targetome changes most
signiﬁcantly as a result of APA are the same between human and
mouse.
Discussion
Sequencing of animal genomes revealed surprisingly small
differences in gene numbers. In the years that followed, much
emphasis has been placed on other factors underlying the
transcriptome and proteome complexity. MiRNAs and RBPs
form a vast regulatory layer whose dynamics has recently come
into focus. The discovery of the systematic 30 UTR shortening in
proliferating compared with resting cells raised the question of
whether this mode of RNA processing serves to bypass repression
by miRNAs and generally upregulates the expression of genes
with tandem poly(A) sites. Here we have combined measure-
ments of relative polyadenylation site use with measurements of
protein levels to investigate this hypothesis in the context of
mouse and human T cell activation. Although we were able to
demonstrate the systematic 30 UTR shortening in both systems,
we did not ﬁnd a correlation between the extent of proximal
polyadenylation site use and the mRNA or the protein levels.
Further inferring the relative rates of decay of short and long 30
UTR isoforms, we found that short 30 UTR isoforms have a
slightly lower decay rate compared with their long 30 UTR
isoforms. Nonetheless, the difference between isoforms appears to
be small, consistent with what has been observed in mouse
embryonic ﬁbroblasts8 and it is not systematic.
Analysing the process of 30 UTR shortening upon proliferation
of mouse and human T cells, we found that although the
phenomenon is conserved, there is little conservation in the set of
genes that exhibit 30 UTR shortening and in the relative change in
proximal/distal processing ratios. In this respect, APA resembles
alternative splicing where individual events are also poorly
conserved between species such as mouse and human42. Two
questions remain at this point unanswered. The ﬁrst concerns the
molecular mechanism that underlies the systematic change in
polyadenylation sites upon cell proliferation. Compelling
evidence has been presented that the U1 snRNP acts as a
protective factor that prevents premature polyadenylation and
that transient limitations in U1 snRNP abundance in speciﬁc
cellular states lead to polyadenylation at proximal sites43,44. Other
proteins such as the mammalian cleavage and polyadenylation
factor I (CFIm) components CFIm 25 and CFIm 68 (refs 16,45)
and the poly(A)-binding protein nuclear 1 (ref. 34) appear to
have similar effects, a reduction in their concentration leading to
polyadenylation at proximal sites. In our data, the CFIm factors as
well as PABPN1 appear to be downregulated at the protein level
in both mouse and human T cells (Supplementary Data 2 and 3).
However, whether these or other factors are at work in
proliferating cells remains to be determined.
The second question concerns the ultimate consequence and
functional relevance of the change in polyadenylation sites.
Although systematic differences in the decay rates of short and
long isoforms were not identiﬁed, transcript stability may still be
regulated via APA, with some short isoforms having higher and
others lower stability relative to their corresponding long
isoforms (see for example, Gupta et al.15). However, the fact
that many of the proteins that lose the most or least binding sites
upon APA are splicing and RNA transport factors suggests that
regulatory effects may be expected at other levels. For example,
one of the factors that appear to preferentially lose sites is YB-1, a
marker of stress granules and processing bodies46. On the other
hand, poly(A)-binding proteins that are involved in the nuclear
export of mRNAs and many other cytoplasmic processes47, lose
substantially fewer sites than expected.
Finally, one hypothesis to consider is that 30 UTR shortening
does not have speciﬁc consequences on gene regulation. Rather, it
could be a complex regulatory system, acting on long 30 UTRs
that may no longer be needed when cells are engaged in a very
deﬁned state of active proliferation. In those circumstances, the 30
UTR shortening may act both to conserve energy, as well as to
prevent the interference of complex, cell type-speciﬁc post-
transcriptional regulatory networks, with the cell cycle pro-
gramme. With the availability of systems that allow genetic
modiﬁcation of mammalian cells48, it may soon become possible
to modify the poly(A) signals and to test the effect of expressing
solely the long 30 UTR isoforms in cells that are induced to
proliferate.
Methods
Isolation and activation of T cells. For mouse T cells, spleen and lymph nodes
were dissected from 8- to 10-week-old female C57BL/6 mice and total, untouched
T cells were isolated by MACS puriﬁcation (Pan T cell isolation kit from Miltenyi
or the mouse T cell isolation kit from Stem Cell Technologies) according to the
manufacturer’s protocol. T cells were activated for 72 h with mouse T-Activator
CD3/CD28 Dynabeads (Gibco/Life Technologies) and 30U of recombinant IL-2
(Peprotech). Corresponding unstimulated cells were from the same T cell pre-
parations. Human T cells from single donor human blood samples were isolated
with the Pan T cell isolation kit from Miltenyi and either left untreated or were
stimulated with human T-Activator CD3/CD28 Dynabeads (Life Technologies)
and 30U of recombinant IL-2 from Peprotech.
30 End sequencing and inference of poly(A) sites. Murine T cell 30 end
sequencing libraries were prepared according to the original A-seq protocol16. To
circumvent the frequently cumbersome size selection step in this protocol, we
developed an improved 30 end sequencing protocol (A-seq2) that we used for the
preparation of the human 30 end sequencing libraries (see Supplementary Methods
for details). The Gene Expression Omnibus (GEO) accession number for the A-seq
libraries is GSE54950.
Sequencing reads were preprocessed to remove 30 adapter sequences and
mapped to the mouse genome (mm9) and human genome (hg19), respectively,
with CLIPZ21. To ensure that only genuine 30 ends are considered, we only used
A-seq reads that contained at least four nucleotides of the adapter sequence. Based
on the precise mapping of the 30 end of reads that mapped to a unique position in
the genome, we computed putative cleavage sites and their abundance at nucleotide
resolution. Putative cleavage sites that had at least seven genomically encoded A
nucleotides in the eight nucleotide region immediately downstream were
considered likely internal priming events and were not used in further analyses.
Finally, closely spaced 30 end sites located in terminal exons of transcripts were
grouped into poly(A) site clusters by applying single-linkage clustering with a
distance threshold of seven nucleotides. Only those clusters that showed a minimal
abundance of ﬁve A-seq reads per million were further analysed. For the mouse
genome, we thereby inferred a total of 15,068 clusters with an average cluster span
of 16 nucleotides. For each cluster, a representative cleavage site was chosen by
ranking individual sites by their expression value in each A-seq library and then
determining the overall top ranked site (majority vote over all A-seq libraries)16.
For 30 end sequencing of human mRNAs, we used a slightly modiﬁed A-seq
procedure (A-seq2, see Supplementary Methods for details). Sequencing reads were
ﬁrst processed based on their expected structure from this protocol. First, only
A-seq2 reads that contained three T residues at positions 5–7 (indicating the
beginning of the poly(A) tail) were selected for further use. From these,
randomized nucleotides at positions 1–4 at the 50 end of the reads (needed for
cluster coordination in Illumina sequencing) were trimmed together with the three
Ts, thus removing seven nucleotides. The reverse complement of the remaining
sequences, presumably representing mRNA 30 ends, was then mapped to the
genome. The rest of the analysis was carried out identically to the murine A-seq
sequences. A total 18,918 poly(A) site clusters were inferred for the human
T cell samples. Summary statistics on the number of mapped reads and tandem
poly(A) sites are provided in Supplementary Tables 7 and 8, respectively. The
nucleotide proﬁle ﬂanking the inferred cleavage sites (Supplementary Fig. 7A)
closely resembles the proﬁle obtained in murine T cells (Supplementary Fig. 2A)
and previous studies16. Also the distribution of polyadenylation motifs upstream
of the cleavage site corresponds to the pattern observed in murine T cells
(Supplementary Fig. 7B).
In order to identify genes that show a marked change in the use of proximal and
distal poly(A) sites, we ﬁrst divided the region between the most proximal and
most distal poly(A) site into two parts of equal length and pooled read counts of
poly(A) sites in the 50 half and in the 30 half. For murine T cell samples, we next
employed the statistical framework DEXseq version 1.8 (ref. 17) to identify genes
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that showed a change in the usage pattern between the proximal and the distal
poly(A) site. A total of 157 genes were identiﬁed to undergo a signiﬁcant change
(adjusted P-value r0.05) in the use of the proximal poly(A) site.
Differential gene expression and GO analysis. For each gene, A-seq reads
mapping to terminal exons of its associated transcript isoforms were counted.
Differential gene expression analysis was performed with DESeq version 1.10
(ref. 49). Genes that showed a log twofold differential regulation and an adjusted
P-valuer0.01 were considered as changing signiﬁcantly. GO analysis of up- and
downregulated genes was performed with Ontologizer version 2.0 (ref. 50).
Prediction of miRNA and RBP target sites in murine 30 UTRs. MiRNA target
predictions were obtained from the ElMMo server release 5 (http://www.mirz.u-
nibas.ch). We restricted the set of target sites to conserved sites by choosing a
minimal ElMMo score of 0.5. For ease of use, we mapped 30 UTR sequences to the
mouse or human genome using GMAP51, and converted predicted transcript
coordinates of miRNA target sites to genomic coordinates. A weighted target site
score was then calculated as the sum over all genes with tandem poly(A) sites, with
the probability of each target site for the miRNA multiplied by the abundance of
the gene’s 30 UTR isoform in which the predicted target site was present. For each
miRNA, we recorded the log2 fold-change (x) of the sum of weighted target site
scores in alternative 30 UTR regions for activated over naive T cells. To assess the
signiﬁcance of the fold-change, we shufﬂed the labels of the miRNA target sites
(corresponding to the cognate miRNAs) that were located in alternative 30 UTR
regions. We performed 500 randomizations and obtained the mean (mx) and
standard deviation (sx) of the log2 fold changes across randomized data sets. We
estimated the signiﬁcance of the observed log2 fold change by the z-score deﬁned as
z¼ (xmx)/sx.
PWMs of the binding motifs of RBPs were obtained from the CISBP-RNA
database (http://cisbp-rna.ccbr.utoronto.ca)32. Only PWMs with category
annotation ‘direct evidence’ in mouse or human were considered. MotEvo was used
to scan murine 30 UTRs (using a background prior of 0.99 and an UFE prior of
200) to predict evolutionarily conserved motif matches33. As input we provided
multiple sequence alignments of nine mammalian species generated with the
ElMMo pipeline26. Computations were performed the same way as done for
miRNAs only replacing the ElMMo score with the score obtained from MotEvo. In
case more than one PWM was present for a given RBP in the database, we
evaluated the predicted binding sites for each of them individually, and used as
background for the site randomization the sites predicted for only one
representative PWM for each RBP. The representative was the PWM with the
highest information content. We only report the results for PWMs that had a
minimum of ten predicted sites in the alternatively processed 30 UTR regions.
Estimation of relative mRNA decay rates of short and long transcript iso-
forms. We used the following model to estimate the relative stability of 30 UTR
isoforms. Let us assume that mRNAs are transcribed from their corresponding
gene at rate c, and are processed at either the proximal or the distal poly(A) site
with frequencies f and 1 f, respectively. Let mS and mL be the decay rates of the
short and long 30 UTR isoforms, respectively. With the dynamics of the short (MS)
and long (ML) isoforms being described by the following equations dMS/dt¼
cf mSMS and dML/dt¼ c(1 f)mLML, and denoting by superscripts A and N the
variables corresponding to activated and naive T cells, we obtain at steady state
MNS ¼ c
N f N
mS
;MNL ¼ c
N ð1 f N Þ
mL
;MAS ¼ c
Af A
mS
;MAL ¼ c
Að1 f AÞ
mL
. From our 30 end sequen-
cing experiments, we obtain ratios of proximal-to-distal site use in the two con-
ditions, that is, RN ¼ MNSMNL and R
A ¼ MASMAL , as well as the ratio in the overall mRNA
expression between the two conditions, Q ¼ MNS þMNLMAS þMAL . With the further notation
a¼mL/mS and b¼ cN/cA, we can express these measured quantities in terms of the
variables of the model deﬁned above as follows
RN ¼ f N1 f N a;RA ¼ f
A
1 f A a;Q ¼ b f
Naþ 1 f N
f Aaþ 1 f A . Note, that we can express the
unknown frequencies of 30 UTR processing at proximal and distal sites in the two
conditions in terms of the measured ratios of proximal-to-distal site use, that is,
f N ¼ RNRN þ a and f A ¼ R
A
RA þ a. Further deﬁning x¼ log(Q), y¼ log(b), z¼ log(a) and
the function gðRN ;RA; zÞ ¼ log ðRN þ 1ÞðRA þ ezÞðRA þ 1ÞðRN þ ezÞ
 
, we obtain x¼ yþ g(RN,RA,z)
(equation 1). That is, the observed log fold-change in total mRNA levels (x) is a
result of the log fold-change in transcription rate (y) and a log fold-change in the
decay rate (g(RN,RA,z)). The latter is a function of the observed ratios of short vs
long isoforms in naive and activated T cells, and of the log-ratio z of decay rates of
the short and long isoforms. Note, that whereas x has been measured, the variables
y and z are both unknown. Thus, we cannot uniquely determine the relative
decay rates for a particular gene, without knowing the relative transcription rates
for that gene in the two conditions. Reasoning that genes that are only regulated
at the level of transcription and not through polyadenylation provide an upper
bound on transcriptional changes, we estimate the distribution of transcription log
fold-changes y from the set of genes that have only a single isoform. We found that
to a good approximation, the distribution of y is a Gaussian with mean
my¼ 0.00154 and standard deviation sy¼ 0.92691, that is,
Pðy jmy ;syÞ ¼ 1sy ﬃﬃﬃﬃ2pp exp  ðxmy Þ
2
2s2y
 
. We further assume that the log-ratio of decay
rates can also be approximated by a Gaussian distribution, that is,
Pðz jmz;szÞ ¼ 1sz ﬃﬃﬃﬃ2pp exp  ðx mzÞ
2
2s2y
 
. Finally, we estimate the parameters mz and sz
by assuming that both y and z were drawn from their respective distributions and
comparing the observed mRNA fold-changes with those expected using equation 1.
In particular, the log fold-changes x were measured in duplicate for each gene and
this allows us to estimate the measurement error of these measurements. Let
ðx1i ; x2i Þ denote the pair of replicate measurements for gene i. Assuming that
measurement errors are Gaussian distributed, we can estimate the variance
of the measurement errors as t2 ¼ 12ðn 2Þ
P
i ðx1i  x2i Þ2. Given particular values
of y and z, the probability to measure a given log fold-change x is given by
Pðx jy; z;RR;RA; tÞ ¼ 1t ﬃﬃﬃﬃ2pp exp  x y gðz;RR ;RAÞð Þ
2
2t2
h i
. By multiplying this condi-
tional probability by the prior probabilities P(y|my,sy) and P(z|mz,sz) and inte-
grating over both y and z we obtain the probability Pðx jRR ;RA; my; mz; sy ;sz; tÞ ¼R
dydzPðx jy; z;RR ;RA; tÞPðy jmy; syÞPðz jmz; szÞ: Note that the integral over
y can easily be performed analytically to obtain Pðx jRR;RA; my ; mz;sy ; sz; tÞ ¼
R
dz 1
2psz
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
t2 þ s2y
p exp  zmzð Þ22s2z 
xmy  g z;RR ;RAð Þð Þ2
2 t2 þ s2yð Þ
 
: This integral, however, can-
not be performed analytically and we therefore carried out the integration
numerically over the range mz±15  sz with MATLAB version R2012B. In order
to evaluate combinations of mz and sz, we calculated the log likelihood of the data
by a grid approach sampling values for mz and sz with a step size of 0.01 from  10
to 10 and 0.01 to 10, respectively.
Quantitative proteomics. A detailed description of the protein quantiﬁcation is
given in the Supplementary Methods.
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